Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001438133-22-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-02 | 2022-02-28 | TNDM | Sheridan John F | Pres, CEO, Dir | M - OptEx | $0.00 | +819 | 7,842 | +12% | $0 |
| D | 2022-03-02 | 2022-02-28 | TNDM | Sheridan John F | Pres, CEO, Dir | F - Tax | $112.43 | -284 | 7,558 | -4% | -$31.9K |
| D | 2022-03-02 | 2022-02-28 | TNDM | Sheridan John F | Pres, CEO, Dir | M - OptEx | $0.00 | +819 | 7,378 | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | M | A | 819 | $0.00 | 7,842 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-28 | F | D | 284 | $112.43 | 7,558 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-02-28 | M | A | 819 | $0.00 | 7,378 | D | — · — to — | 819 Common Stock | (F2) Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F3) Each RSU represents a contingent right to receive one share of common stock of the Company. (F4) RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |